Keywords: kirin, licenses, shire, agrylin, japan, brewery, obtained
Kirin licenses Shire's Agrylin in Japan
Article | 05 January 2004
Japan's Kirin Brewery has obtained the development and commercializationrights to UK-based Shire Pharmaceuticals' Agrylin (anagrelide hydrochloride) in Japan.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
